<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38966550</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Evaluating myelophil, a 30% ethanol extract of <i>Astragalus membranaceus</i> and <i>Salvia miltiorrhiza</i>, for alleviating fatigue in long COVID: a real-world observational study.</ArticleTitle><Pagination><StartPage>1394810</StartPage><MedlinePgn>1394810</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1394810</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2024.1394810</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Persistent post-infectious symptoms, predominantly fatigue, characterize Long COVID. This study investigated the efficacy of Myelophil (MYP), which contains metabolites extracted from <i>Astragalus membranaceus</i> and <i>Salvia miltiorrhiza</i> using 30% ethanol, in alleviating fatigue among subjects with Long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this prospective observational study, we enrolled subjects with significant fatigue related to Long COVID, using criteria of scores of 60 or higher on the modified Korean Chalder Fatigue scale (mKCFQ11), or five or higher on the Visual Analog Scale (VAS) for brain fog. Utilizing a single-arm design, participants were orally administered MYP (2,000&#xa0;mg daily) for 4&#xa0;weeks. Changes in fatigue severity were assessed using mKCFQ11, Multidimensional Fatigue Inventory (MFI-20), and VAS for fatigue and brain fog. In addition, changes in quality of life using the short form 12 (SF-12) were also assessed along with plasma cortisol levels.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 50 participants (18 males, 32 females) were enrolled; 49 were included in the intention-to-treat analysis with scores of 66.9 &#xb1; 11.7 on mKCFQ11 and 6.3 &#xb1; 1.5 on the brain fog VAS. After 4&#xa0;weeks of MYP administration, there were statistically significant improvements in fatigue levels: mKCFQ11 was measured at 34.8 &#xb1; 17.1 and brain fog VAS at 3.0 &#xb1; 1.9. Additionally, MFI-20 decreased from 64.8 &#xb1; 9.8 to 49.3 &#xb1; 10.8, fatigue VAS dropped from 7.4 &#xb1; 1.0 to 3.4 &#xb1; 1.7, SF-12 scores rose from 53.3 &#xb1; 14.9 to 78.6 &#xb1; 14.3, and plasma cortisol levels also elevated from 138.8 &#xb1; 50.1 to 176.9 &#xb1; 62.0&#xa0;/mL. No safety concerns emerged during the trial.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Current findings underline MYP's potential in managing Long COVID-induced fatigue. However, comprehensive studies remain imperative.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="UNASSIGNED">https://cris.nih.go.kr, identifier KCT0008948.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Joung, Lee, Choi, Kim, Oh, Seo and Son.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joung</LastName><ForeName>Jin-Yong</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Daejeon Good-morning Korean Medicine Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Seok</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yujin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoon Jung</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Hyeon-Muk</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Hyun-Sik</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Chang-Gue</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Institute of Bioscience and Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Astragalus membranaceus</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myelophil</Keyword><Keyword MajorTopicYN="N">Salvia miltiorrhiza</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>5</Day><Hour>4</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38966550</ArticleId><ArticleId IdType="pmc">PMC11222562</ArticleId><ArticleId IdType="doi">10.3389/fphar.2024.1394810</ArticleId><ArticleId IdType="pii">1394810</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahn Y.-C., Lee J.-S., Son C.-G. (2020). Reliability and validity of the modified Korean version of the chalder fatigue scale (mKCFQ11). Healthc. Basel Switz. 8, 427. 10.3390/healthcare8040427</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040427</ArticleId><ArticleId IdType="pmc">PMC7712859</ArticleId><ArticleId IdType="pubmed">33114401</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L., Grant W. B., Frias-Toral E., Vetrani C., Verde L., de Alteriis G., et al. (2022). Dietary recommendations for post-COVID-19 syndrome. Nutrients 14, 1305. 10.3390/nu14061305</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14061305</ArticleId><ArticleId IdType="pmc">PMC8954128</ArticleId><ArticleId IdType="pubmed">35334962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasco E. E., Dukes K., Jones D., Comellas A. P., Hoffman R. M., Garg A. (2022). Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID. Int. J. Environ. Res. Public. Health 19, 15499. 10.3390/ijerph192315499</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315499</ArticleId><ArticleId IdType="pmc">PMC9737348</ArticleId><ArticleId IdType="pubmed">36497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher D. J., Isaac B. T. J., John F. B., Shankar D., Samuel P., Gupta R., et al. (2024). Impact of post-COVID-19 lung damage on pulmonary function, exercise tolerance and quality of life in Indian subjects. PLOS Glob. Public Health 4, e0002884. 10.1371/journal.pgph.0002884</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0002884</ArticleId><ArticleId IdType="pmc">PMC10833535</ArticleId><ArticleId IdType="pubmed">38300923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H.-J., Lin C.-W., Hsiao M.-Y., Wang T.-G., Liang H.-W. (2023). Long COVID and rehabilitation. J. Formos. Med. Assoc. 123, S61&#x2013;S69. 10.1016/j.jfma.2023.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10101546</ArticleId><ArticleId IdType="pubmed">37061399</ArticleId></ArticleIdList></Reference><Reference><Citation>Coscia F., Di Filippo E. S., Gigliotti P. V., Fan&#xf2;-Illic G. (2023). Effect of physical activity on long COVID fatigue: an unsolved enigma. Eur. J. Transl. Myol. 33, 11639. 10.4081/ejtm.2023.11639</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejtm.2023.11639</ArticleId><ArticleId IdType="pmc">PMC10583148</ArticleId><ArticleId IdType="pubmed">37667865</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F., Erdfelder E., Lang A.-G., Buchner A. (2007). G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175&#x2013;191. 10.3758/BF03193146</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03193146</ArticleId><ArticleId IdType="pubmed">17695343</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnigan L. E. M., Cassar M. P., Koziel M. J., Pradines J., Lamlum H., Azer K., et al. (2023). Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. eClinicalMedicine 59, 101946. 10.1016/j.eclinm.2023.101946</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101946</ArticleId><ArticleId IdType="pmc">PMC10102537</ArticleId><ArticleId IdType="pubmed">37223439</ArticleId></ArticleIdList></Reference><Reference><Citation>Harandi A. A., Pakdaman H., Medghalchi A., Kimia N., Kazemian A., Siavoshi F., et al. (2024). A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue. Sci. Rep. 14, 1343. 10.1038/s41598-024-51904-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-51904-z</ArticleId><ArticleId IdType="pmc">PMC10792128</ArticleId><ArticleId IdType="pubmed">38228731</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich M., Jalil B., Abdel-Tawab M., Echeverria J., Kuli&#x107; &#x17d;., McGaw L. J., et al. (2022). Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines. Front. Pharmacol. 13, 953205. 10.3389/fphar.2022.953205</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.953205</ArticleId><ArticleId IdType="pmc">PMC9514875</ArticleId><ArticleId IdType="pubmed">36176427</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung J.-Y., Lee J.-S., Cho J.-H., Lee D.-S., Ahn Y.-C., Son C.-G. (2019a). The efficacy and safety of Myelophil, an ethanol extract mixture of astragali radix and Salviae radix, for chronic fatigue syndrome: a randomized clinical trial. Front. Pharmacol. 10, 991. 10.3389/fphar.2019.00991</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00991</ArticleId><ArticleId IdType="pmc">PMC6746924</ArticleId><ArticleId IdType="pubmed">31551788</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung J.-Y., Lee J.-S., Cho J.-H., Lee D.-S., Son C.-G. (2019b). Acute and repeated toxicological study of Myelophil, an ethanol extract of a mixture of Astragali Radix and Salviae Miltiorrhizae Radix, in beagle dogs. BMC Complement. Altern. Med. 19, 166. 10.1186/s12906-019-2588-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-019-2588-3</ArticleId><ArticleId IdType="pmc">PMC6615141</ArticleId><ArticleId IdType="pubmed">31286942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-G., Lee J.-S., Choi M.-K., Han J.-M., Son C.-G. (2014). Ethanolic extract of Astragali radix and Salviae radix prohibits oxidative brain injury by psycho-emotional stress in whisker removal rat model. PloS One 9, e98329. 10.1371/journal.pone.0098329</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098329</ArticleId><ArticleId IdType="pmc">PMC4037216</ArticleId><ArticleId IdType="pubmed">24870587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-G., Lee J.-S., Han J.-M., Lee J.-S., Choi M.-K., Son S.-W., et al. (2013). Myelophil attenuates brain oxidative damage by modulating the hypothalamus-pituitary-adrenal (HPA) axis in a chronic cold-stress mouse model. J. Ethnopharmacol. 148, 505&#x2013;514. 10.1016/j.jep.2013.04.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2013.04.046</ArticleId><ArticleId IdType="pubmed">23665312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Ku B., Kim K. H. (2016). Validation of the qi blood yin yang deficiency questionnaire on chronic fatigue. Chin. Med. 11, 24. 10.1186/s13020-016-0092-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-016-0092-y</ArticleId><ArticleId IdType="pmc">PMC4852426</ArticleId><ArticleId IdType="pubmed">27141228</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Lipkin W. I. (2023). ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front. Med. 10, 1187163. 10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuut T. A., M&#xfc;ller F., Csorba I., Braamse A., Aldenkamp A., Appelman B., et al. (2023). Efficacy of cognitive-behavioral therapy targeting severe fatigue following coronavirus disease 2019: results of a randomized controlled trial. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 77, 687&#x2013;695. 10.1093/cid/ciad257</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad257</ArticleId><ArticleId IdType="pmc">PMC10495128</ArticleId><ArticleId IdType="pubmed">37155736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-S., Kim H.-G., Han J.-M., Kim Y.-A., Son C.-G. (2015). Anti-fatigue effect of Myelophil in a chronic forced exercise mouse model. Eur. J. Pharmacol. 764, 100&#x2013;108. 10.1016/j.ejphar.2015.06.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.06.055</ArticleId><ArticleId IdType="pubmed">26142828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-S., Kim W.-Y., Jeon Y.-J., Lee S.-B., Lee D.-S., Son C.-G. (2019). Antidepressant-like activity of Myelophil via attenuation of microglial-mediated neuroinflammation in mice undergoing unpredictable chronic mild stress. Front. Pharmacol. 10, 683. 10.3389/fphar.2019.00683</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00683</ArticleId><ArticleId IdType="pmc">PMC6585390</ArticleId><ArticleId IdType="pubmed">31263417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.-J., Son C.-G. (2022). Comparison of assessment scores for fatigue between multidimensional fatigue inventory (MFI-K) and modified chalder fatigue scale (mKCFQ). J. Transl. Med. 20, 8. 10.1186/s12967-021-03219-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03219-0</ArticleId><ArticleId IdType="pmc">PMC8722196</ArticleId><ArticleId IdType="pubmed">34980164</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunt J., Hemming S., Burton K., Elander J., Baraniak A. (2022). What workers can tell us about post-COVID workability. Occup. Med. Oxf. Engl. 74, 15&#x2013;23. 10.1093/occmed/kqac086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqac086</ArticleId><ArticleId IdType="pmc">PMC9384751</ArticleId><ArticleId IdType="pubmed">35968657</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira C. R., Jason L. A., Unutmaz D., Bateman L., Vernon S. D. (2023). Improvement of Long COVID symptoms over one year. Front. Med. 9, 1065620. 10.3389/fmed.2022.1065620</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1065620</ArticleId><ArticleId IdType="pmc">PMC9868805</ArticleId><ArticleId IdType="pubmed">36698810</ArticleId></ArticleIdList></Reference><Reference><Citation>Qanneta R. (2022). Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: similarities and differences of two peas in a pod. Reumatol. Clin. 18, 626&#x2013;628. 10.1016/j.reuma.2022.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2022.05.003</ArticleId><ArticleId IdType="pmc">PMC9167847</ArticleId><ArticleId IdType="pubmed">35693424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A., Jadhav S. B., Shah N. (2021). A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Medicines 8, 47. 10.3390/medicines8090047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicines8090047</ArticleId><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A. B., Greene C., Dayaramani C., Rauchman S. H., Stecker M. M., De Leon J., et al. (2023). Long COVID, the brain, nerves, and cognitive function. Neurol. Int. 15, 821&#x2013;841. 10.3390/neurolint15030052</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell G., Lightman S. (2019). The human stress response. Nat. Rev. Endocrinol. 15, 525&#x2013;534. 10.1038/s41574-019-0228-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-019-0228-0</ArticleId><ArticleId IdType="pubmed">31249398</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.-H., Won S.-K., Eom G.-H., Lee D.-S., Park B.-J., Lee J.-S., et al. (2021). Improvement effects of Myelophil on symptoms of chronic fatigue syndrome in a reserpine-induced mouse model. Int. J. Mol. Sci. 22, 10199. 10.3390/ijms221910199</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910199</ArticleId><ArticleId IdType="pmc">PMC8508381</ArticleId><ArticleId IdType="pubmed">34638540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Newton J., Watson S. (2013). A review of hypothalamic-pituitary-adrenal Axis function in chronic fatigue syndrome. ISRN Neurosci. 2013, 784520. 10.1155/2013/784520</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/784520</ArticleId><ArticleId IdType="pmc">PMC4045534</ArticleId><ArticleId IdType="pubmed">24959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Verveen A., M&#xfc;ller F., Lloyd A., Moss-Morris R., Omland T., Penninx B., et al. (2022). A research agenda for post-COVID-19 fatigue. J. Psychosom. Res. 154, 110726. 10.1016/j.jpsychores.2022.110726</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.110726</ArticleId><ArticleId IdType="pmc">PMC8786369</ArticleId><ArticleId IdType="pubmed">35086054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T. L., Weitzer D. J. (2021). Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Med. (Mex.) 57, 418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M. J., Luo X., Thomas R., Shin M.-G., Neidleman J., et al. (2024). Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218&#x2013;225. 10.1038/s41590-023-01724-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>